1.
Cancer Chemother Pharmacol
; 7(2-3): 93-8, 1982.
Article
in English
| MEDLINE
| ID: mdl-7044596
ABSTRACT
The unique biological properties and therapeutic efficacy of the podophyllotoxin derivatives, Vumon (VM26, teniposide) and Vepesid (VP16-213, etoposide), are stimulating the interest of both laboratory and clinical researchers. Investigations on new pharmaceutical formulations, pharmacokinetics and metabolism are providing more appropriate information in drug administration; experimental chemotherapy indicates that, among others, cytosine arabinoside and cisplatin are highly synergistic with podophyllotoxins; single agent and combination treatment clinical trials are defining the respective role of Vumon and Vepesid in cancer chemotherapy.
Subject(s)
Etoposide/pharmacology , Podophyllotoxin/analogs & derivatives , Teniposide/metabolism , Teniposide/pharmacology , Chemistry, Pharmaceutical , Drug Compounding , Drug Stability , Drug Synergism , Drug Therapy, Combination , Etoposide/metabolism , Humans , Kinetics
2.
Eur J Cancer (1965)
; 16(12): 1555-9, 1980 Dec.
Article
in English
| MEDLINE
| ID: mdl-7227430
3.
Rev Med Brux
; 1(5): 325-9, 1980 May.
Article
in French
| MEDLINE
| ID: mdl-7008130
4.
Buenos Aires; Letra Viva Ediciones; 1a. ed; 1999. 300 p. ^e23 cm.
Monography
in Spanish
|
LILACS-Express
| BINACIS
| ID: biblio-1199198
5.
Buenos Aires; Letra Viva Ediciones; 1a. ed; 1999. 300 p. 23 cm. (74152).
Monography
in Spanish
| BINACIS
| ID: bin-74152
